ATE3859T1 - Pyridoxin-derivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung. - Google Patents

Pyridoxin-derivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung.

Info

Publication number
ATE3859T1
ATE3859T1 AT81870023T AT81870023T ATE3859T1 AT E3859 T1 ATE3859 T1 AT E3859T1 AT 81870023 T AT81870023 T AT 81870023T AT 81870023 T AT81870023 T AT 81870023T AT E3859 T1 ATE3859 T1 AT E3859T1
Authority
AT
Austria
Prior art keywords
processes
production
therapeutic use
pyridoxine derivatives
pyridoxine
Prior art date
Application number
AT81870023T
Other languages
English (en)
Inventor
Marcel Descamps
Marcel Urbain
Original Assignee
S.A. Labaz - Sanofi N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by S.A. Labaz - Sanofi N.V. filed Critical S.A. Labaz - Sanofi N.V.
Application granted granted Critical
Publication of ATE3859T1 publication Critical patent/ATE3859T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • C07D213/66—One oxygen atom attached in position 3 or 5 having in position 3 an oxygen atom and in each of the positions 4 and 5 a carbon atom bound to an oxygen, sulphur, or nitrogen atom, e.g. pyridoxal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT81870023T 1980-05-19 1981-05-15 Pyridoxin-derivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung. ATE3859T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8016516 1980-05-19
EP81870023A EP0040591B1 (de) 1980-05-19 1981-05-15 Pyridoxin-Derivate, Verfahren zu ihrer Herstellung und ihre therapeutische Verwendung

Publications (1)

Publication Number Publication Date
ATE3859T1 true ATE3859T1 (de) 1983-07-15

Family

ID=10513518

Family Applications (1)

Application Number Title Priority Date Filing Date
AT81870023T ATE3859T1 (de) 1980-05-19 1981-05-15 Pyridoxin-derivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung.

Country Status (32)

Country Link
US (1) US4374841A (de)
EP (1) EP0040591B1 (de)
JP (1) JPS5711966A (de)
AR (1) AR226356A1 (de)
AT (1) ATE3859T1 (de)
AU (1) AU542463B2 (de)
BG (1) BG35327A3 (de)
CA (1) CA1152080A (de)
CS (1) CS223842B2 (de)
DD (1) DD159071A5 (de)
DE (1) DE3160480D1 (de)
DK (1) DK217481A (de)
EG (1) EG15890A (de)
ES (1) ES502276A0 (de)
FI (1) FI811525L (de)
GR (1) GR82343B (de)
HU (1) HU183441B (de)
IE (1) IE51179B1 (de)
IL (1) IL62602A (de)
IN (1) IN151915B (de)
IS (1) IS1183B6 (de)
MA (1) MA19147A1 (de)
NO (1) NO811680L (de)
NZ (1) NZ196766A (de)
OA (1) OA06811A (de)
PL (1) PL129213B1 (de)
PT (1) PT72992B (de)
RO (1) RO81943A (de)
SU (1) SU1077566A3 (de)
YU (1) YU126281A (de)
ZA (1) ZA812448B (de)
ZW (1) ZW9681A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4663354A (en) * 1984-04-26 1987-05-05 Klinge Pharma Gmbh Use of etilefrin and etilefrin pivalate in the long term treatment of circulatory disorders not due to hypotonia
DE3519693A1 (de) * 1985-06-01 1987-01-02 Basf Ag Pyridin-derivate, ihre herstellung und verwendung
US6051587A (en) * 1998-04-16 2000-04-18 Medicure, Inc. Treatment of iatrogenic and age-related hypertension and pharmaceutical compositions useful therein
US6043259A (en) * 1998-07-09 2000-03-28 Medicure Inc. Treatment of cardiovascular and related pathologies
ATE306489T1 (de) 1999-03-08 2005-10-15 Medicure Inc Pyridoxal-analoge zur behandlung von störungen ausgelöst durch einen vitamin b6 mangel
AU5840200A (en) 1999-07-13 2001-01-30 Medicure Inc. Treatment of diabetes and related pathologies
WO2001013900A2 (en) 1999-08-24 2001-03-01 Medicure International Inc. Compositions for the treatment of cardiovascular diseases containing pyridoxal compounds and cardiovascular compounds
US7442689B2 (en) * 2000-02-29 2008-10-28 Medicure International Inc. Cardioprotective phosphonates and malonates
DE60110054T2 (de) 2000-02-29 2006-03-09 Medicure International Inc. Cardioprotektive phosphonate
US6586414B2 (en) 2000-03-28 2003-07-01 Medicure International Inc. Treatment of cerebrovascular disease
US6548519B1 (en) 2001-07-06 2003-04-15 Medicure International Inc. Pyridoxine and pyridoxal analogues: novel uses
US6897228B2 (en) * 2000-07-07 2005-05-24 Medicure International Inc. Pyridoxine and pyridoxal analogues: new uses
NZ523815A (en) 2000-07-07 2004-07-30 Medicure Int Inc Pyridoxine and pyridoxal analogues: cardiovascular therapeutics
US20040121988A1 (en) * 2001-03-28 2004-06-24 Medicure International Inc. Treatment of cerebrovascular disease
JP4048166B2 (ja) * 2002-11-18 2008-02-13 三井製糖株式会社 血糖値上昇抑制剤及び体脂肪蓄積抑制剤並びに食用材料
US20040186077A1 (en) * 2003-03-17 2004-09-23 Medicure International Inc. Novel heteroaryl phosphonates as cardioprotective agents
AU2004224566A1 (en) * 2003-03-27 2004-10-07 Medicure Inc. Compositions for treating angina
US20060019929A1 (en) * 2004-07-07 2006-01-26 Albert Friesen Combination therapies employing platelet aggregation drugs
US20070060549A1 (en) * 2004-08-10 2007-03-15 Friesen Albert D Combination therapies employing ace inhibitors and uses thereof for the treatment of diabetic disorders
WO2006050598A1 (en) * 2004-10-28 2006-05-18 Medicure International Inc. Dual antiplatelet/anticoagulant pyridoxine analogs
US20060094749A1 (en) * 2004-10-28 2006-05-04 Medicure International Inc. Substituted pyridoxines as anti-platelet agents
US7459468B2 (en) * 2004-10-28 2008-12-02 Medicure International, Inc. Aryl sulfonic pyridoxines as antiplatelet agents
JP2009517411A (ja) * 2005-11-28 2009-04-30 メディキュア インターナショナル インコーポレーテッド 心血管及び関連病状の処置のための調剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4115575A (en) * 1973-02-20 1978-09-19 Ciba-Geigy Corporation 2-(3-Amino-2-hydroxy-propoxy)-pyrazines
AR206801A1 (es) * 1973-02-20 1976-08-23 Ciba Geigy Ag Procedimiento para la elaboracion de derivados del 1-pirid loxi-2-hidroxi-3-amino-propano
GB1485919A (en) * 1975-08-12 1977-09-14 Grindstedvaerket As Pyridine derivatives
DE2711655A1 (de) * 1977-03-17 1978-09-21 Basf Ag Pyridinyl-aminoalkylaether
US4210653A (en) * 1978-06-27 1980-07-01 Merck & Co., Inc. Pyridyloxypropanolamines

Also Published As

Publication number Publication date
EG15890A (en) 1987-03-30
DK217481A (da) 1981-11-20
NZ196766A (en) 1984-02-03
CS223842B2 (en) 1983-11-25
US4374841A (en) 1983-02-22
PL231193A1 (de) 1982-07-05
IL62602A (en) 1984-06-29
HU183441B (en) 1984-05-28
ES8203845A1 (es) 1982-04-01
RO81943B (ro) 1983-05-30
RO81943A (ro) 1983-06-01
PT72992B (en) 1982-07-01
DD159071A5 (de) 1983-02-16
OA06811A (fr) 1982-12-31
AU7053581A (en) 1981-11-26
GR82343B (de) 1984-12-13
DE3160480D1 (en) 1983-07-28
PL129213B1 (en) 1984-04-30
AU542463B2 (en) 1985-02-21
MA19147A1 (fr) 1981-12-31
YU126281A (en) 1984-02-29
ZA812448B (en) 1982-04-28
SU1077566A3 (ru) 1984-02-29
IS1183B6 (is) 1985-05-13
IE811085L (en) 1981-11-19
IE51179B1 (en) 1986-10-29
ES502276A0 (es) 1982-04-01
EP0040591B1 (de) 1983-06-22
FI811525L (fi) 1981-11-20
NO811680L (no) 1981-11-20
ZW9681A1 (en) 1982-01-20
IS2631A7 (is) 1981-11-11
IL62602A0 (en) 1981-06-29
JPS5711966A (en) 1982-01-21
CA1152080A (en) 1983-08-16
AR226356A1 (es) 1982-06-30
EP0040591A1 (de) 1981-11-25
BG35327A3 (en) 1984-03-15
PT72992A (en) 1981-06-01
IN151915B (de) 1983-09-03

Similar Documents

Publication Publication Date Title
ATE3859T1 (de) Pyridoxin-derivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung.
DE3869205D1 (de) 2-phenylpurinon-derivate, verfahren zu ihrer herstellung, ihre verwendung sowie zwischenprodukte.
DE3784401D1 (de) Karbostyril-derivate und ihre salze, verfahren zu ihrer herstellung und diese enthaltende kardiotonische zusammensetzung.
ATE36701T1 (de) Spergualinaehnliche derivate, verfahren zu ihrer herstellung und ihre verwendung als heilmittel.
ATE9160T1 (de) Thienopyridinonderivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung.
ATE32459T1 (de) Substituierte phenylsulfonyloxybenzimidazolcarbaminate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
ATE259T1 (de) Alpha-azolyl-beta-hydroxy-ketone, verfahren zu ihrer herstellung und ihre verwendung als fungizide.
ATE73758T1 (de) 2,2-difluorcyclopropylethanderivate, verfahren zu ihrer herstellung und ihre verwendung als schaedlingsbekaempfungsmittel.
ATE406T1 (de) Alpha-azolyl-keto-derivate, verfahren zu ihrer herstellung und ihre verwendung als fungizide.
ATE4205T1 (de) Acylierte triazolyl-gamma-fluorpinakolylderivate, verfahren zu ihrer herstellung und ihre verwendung als fungizide.
DE3581725D1 (de) Aminoacyllabdane, verfahren und zwischenprodukte zu ihrer herstellung und ihre verwendung als arzneimittel.
ATE1360T1 (de) Fungizide mittel, verfahren zu ihrer herstellung sowie ihre verwendung als fungizide.
ATE2072T1 (de) Fluorierte 1-triazolyl-butan-derivate, verfahren zu ihrer herstellung und ihre verwendung als fungizide.
DE3677812D1 (de) Polyhydroxypolyether, verfahren zu ihrer herstellung und ihre verwendung.
ATE38512T1 (de) Phenylen-substituierte, spergualinaehnliche derivate, verfahren zu ihrer herstellung und ihre verwendung als heilmittel.
DE3586324D1 (de) Tetrahydrophthalimidderivate, verfahren zu ihrer herstellung und ihre verwendung.
ATE20058T1 (de) Substituierte azolyl-phenoxy-derivate, verfahren zu ihrer herstellung und ihre verwendung als fungizide.
ATE3207T1 (de) Triazolylphenacyl-pyridyl-ether-derivate, verfahren zu ihrer herstellung sowie ihre verwendung als fungizide.
DE3673734D1 (de) Xanthinderivate, verfahren zu ihrer herstellung und ihre verwendung als medikamente.
DE3484023D1 (de) Azolylmethylcycloalkane, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
DE3583928D1 (de) Cephalosporinzwischenprodukte, verfahren zu ihrer herstellung und ihre verwendung.
ATE8888T1 (de) N,n-dialkyl -0-(pyrazol-5-yl)-carbaminsaeureester, verfahren zu ihrer herstellung und ihre verwendung als insektizide.
DE3768416D1 (de) Iminooxazolidine, verfahren zu ihrer herstellung und ihre verwendung.
ATE1675T1 (de) 2-phenyl-4-pyron-derivate, verfahren zu ihrer herstellung und ihre verwendung als fungizide.
ATE9696T1 (de) 2-azolylmethyl-1,3-dioxolan- und -dioxanderivate, verfahren zu ihrer herstellung und ihre verwendung als fungizide.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee